BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33592112)

  • 1. Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy.
    Pendlebury A; Radeva M; Rose PG
    J Surg Oncol; 2021 Apr; 123(5):1292-1298. PubMed ID: 33592112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.
    Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL
    Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
    Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
    Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer.
    Jeong NH; Lee JM; Lee JK; Kim MK; Kim YJ; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Ann Surg Oncol; 2010 Nov; 17(11):2951-7. PubMed ID: 20556522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
    Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
    Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
    Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
    Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions.
    Sullivan MW; Philp L; Kanbergs AN; Safdar N; Oliva E; Bregar A; Del Carmen MG; Eisenhauer EL; Goodman A; Muto M; Sisodia RC; Growdon WB
    Gynecol Oncol; 2021 Sep; 162(3):613-618. PubMed ID: 34247769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus.
    Onstad M; Ducie J; Fellman BM; Abu-Rustum NR; Leitao M; Mariani A; Multinu F; Lu KH; Soliman P
    Int J Gynecol Cancer; 2020 Apr; 30(4):485-490. PubMed ID: 31980487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
    Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
    Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.